CATX
Perspective Therapeutics Inc.
3.00$
-0.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2019 | 2020 | 2020 | 2021 | 2021 | 2022 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -69.0% | -37.6% | -37.6% | -28.2% | -28.2% | -71.4% | -71.4% | -192.1% | -171.3% | -2,574.1% | -1,258.2% | -9,330.8% | |
| 1.9% | 1.5% | 1.5% | 1.5% | 1.5% | 2.3% | 2.3% | 6.0% | 4.8% | 68.8% | 158.6% | 367.8% | |
| 5.7% | 5.1% | 5.1% | 3.8% | 3.8% | 10.1% | 10.1% | 14.9% | 18.9% | 260.7% | 370.5% | 1,014.3% | |
| – | – | 4.4% | – | 4.0% | – | 10.1% | – | – | – | – | – | |
| -7.1% | -8.6% | -8.6% | -0.7% | -0.7% | -17.1% | -17.1% | -32.1% | 4.8% | 203.6% | 2,188.0% | 190.2% | |
| 6.1% | 2.8% | 2.8% | 3.8% | 3.8% | 2.5% | 2.5% | 5.2% | 4.3% | 74.8% | 3,742.4% | 1,442.2% | |
| – | -3.0% | -3.0% | -4.1% | -4.1% | – | -2.6% | -535.3% | – | 1,699.7% | -15,057.2% | 4,663.8% | |
| 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -4.7% | -3.3% | -5.9% | |
| 100.8% | 10.3% | 10.3% | 643.4% | 643.4% | 0.5% | 0.5% | 0.5% | 0.8% | 54.7% | 19,902.7% | 1,165.7% | |
| 37.3% | -30.3% | -30.3% | 611.1% | 611.1% | -73.5% | -73.5% | -146.6% | 2.6% | -819.7% | 3,587.3% | -3,501.2% | |
| -75.1% | -40.4% | -40.4% | -32.0% | -32.0% | -73.9% | -73.9% | -197.3% | -175.6% | -2,648.9% | -5,000.6% | -10,773.0% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.